Evidence map›Paper›PMID 36483192›Full record

ArticleChina CDC weekly2022

An Outbreak of SARS-CoV-2 Omicron Subvariant BA.2.76 in an Outdoor Park - Chongqing Municipality, China, August 2022.

Li Qi, Wenge Tang, Ju Wang, Yu Xiong, Yi Yuan, Baisong Li, Lin Yang, Tingting Li, Lianjian Yang, Xiaoyuan Su and 2 more

Abstract read
In one paragraph

Article in China CDC weekly, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Rise of the BQ.1.1.37 SARS-CoV-2 Sublineage, Italy.Diagnostics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Li QiChongqing Center for Disease Control and Prevention, Chongqing Municipality, China.
Wenge TangChongqing Center for Disease Control and Prevention, Chongqing Municipality, China.
Ju WangChongqing Center for Disease Control and Prevention, Chongqing Municipality, China.
Yu XiongChongqing Center for Disease Control and Prevention, Chongqing Municipality, China.
Yi YuanChongqing Center for Disease Control and Prevention, Chongqing Municipality, China.
Baisong LiChongqing Center for Disease Control and Prevention, Chongqing Municipality, China.
Lin YangChongqing Center for Disease Control and Prevention, Chongqing Municipality, China.
Tingting LiChongqing Center for Disease Control and Prevention, Chongqing Municipality, China.
Lianjian YangShapingba Center for Disease Control and Prevention, Chongqing Municipality, China.
Xiaoyuan SuYubei Center for Disease Control and Prevention, Chongqing Municipality, China.
Qin LiChongqing Center for Disease Control and Prevention, Chongqing Municipality, China.
Lijie ZhangChinese Center for Disease Control and Prevention, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariant has a stronger transmission capacity and faster transmission speed than the previous strain. What is added by this report?: The first coronavirus disease 2019 (COVID-19) case infected with the SARS-CoV-2 Omicron subvariant BA.2.76 who caused local transmission was reported in Chongqing Municipality on August 16, 2022. For 35 minutes, the Patient Zero jogged along a lake at a local park without wearing a mask. Among the 2,836 people potentially exposed at the time, 39 tested positive. Overall, 38 out of 39 cases did not wear a mask on the morning of August 16. All 39 cases lacked any previous exposure to the variant before testing positive on their nucleic acid test. What are the implications for public health practice?: It is essential to maintain personal wellbeing by ensuring one maintains personal protection and follows regulated guidelines such as maintaining safe distances from others both indoors and outdoors.

Indexed as

COVID-19OutdoorSARS-CoV-2Transmission

Identifiers

PMID36483192
PMCPMC9713573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.